SILENCE THERAPEUTICS PLC-ADR (SLN) Stock Income Statement
NASDAQ:SLN • US82686Q1013
Current stock price
6.91 USD
-0.44 (-5.99%)
Last:
| TTM (2025-9-30) | 2020 (2020-12-31) | 2019 (2019-12-31) | 2018 (2018-12-31) | 2017 (2017-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 43.78M | 5.48M | 244.00K | 0.00 | 16.00K | |||
| Cost Of Goods | 12.01M | 3.76M | N/A | N/A | N/A | |||
| Gross Profit | 31.77M | 1.72M | N/A | N/A | N/A | |||
| Operating Expenses | 172.38M | 37.56M | 22.98M | 20.57M | 14.41M | |||
| Research and Development | 126.89M | 20.21M | 13.34M | 9.74M | 7.94M | |||
| Selling, General, and Administrative Expenses | 45.49M | 13.98M | 9.64M | 10.83M | 6.46M | |||
| Operating Income | -140.61M | -35.85M | -22.73M | -20.57M | -14.39M | |||
| Interest Income/Expense | -7.10M | -194.00K | -136.00K | 45.00K | 10.66M | |||
| Other Income/Expense | 27.74M | N/A | N/A | N/A | -49.00K | |||
| Income Before Taxes | -121.30M | -36.04M | -22.87M | -20.53M | -3.77M | |||
| Income Tax | 856.00K | -3.49M | -3.29M | -2.12M | -2.16M | |||
| Net Income | -122.15M | -32.55M | -19.58M | -18.41M | -1.62M | |||
| EBITDA | N/A | -35.35M | -22.25M | -20.17M | -13.96M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -2.61 | -0.40 | -0.26 | -0.26 | -0.02 | |||
| Non GAAP EPS | N/A | -0.40 | N/A | N/A | N/A | |||
| Statistics | ||||||||
| Gross Profit Margin | 72.56% | 31.34% | N/A | N/A | N/A | |||
| Profit Margin | -278.99% | -594.03% | -8025.41% | N/A | -10112.50% | |||
| Operating Profit Margin | -321.15% | -654.26% | -9317.21% | N/A | -89943.75% | |||
All data in USD